Physician profile
Barbara Hisler
NPI 1023067535
$3,192.56
in general payments reported to CMS, 2019-2025
23 companies · $393 in 2025
The $393 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $52.71 · 2021: $158 · 2022: $202 · 2023: $311 · 2024: $1,151 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,755 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.67 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $554.25 | 2019-2025 | |
| Galderma Laboratories, L.P. | $358.57 | 2019-2024 | |
| Amgen INC. | $291.35 | 2021-2025 | Otezla, Otezla |
| Pfizer INC. | $253.53 | 2019-2024 | |
| Almirall LLC | $251.05 | 2019-2025 | Klisyri, Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $229.15 | 2019-2025 | Cabtreo |
| Incyte Corporation | $189.93 | 2022-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $175.90 | 2021-2024 | Winlevi, Absorica Ld |
| Celgene Corporation | $172.15 | 2019 | |
| Dermira, INC. | $124.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $116.85 | 2022-2023 | Sotyktu |
| Sandoz INC. | $90.66 | 2019 | |
| Dermavant Sciences, INC. | $62.13 | 2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $59.96 | 2023-2024 | Zoryve |
| Leo Pharma INC. | $53.31 | 2019-2024 | Adbry |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $48.40 | 2025 | Vtama |
| Encore Dermatology INC. | $37.64 | 2019-2020 | |
| Verrica Pharmaceuticals INC. | $23.58 | 2023 | Ycanth |
| Regeneron Healthcare Solutions, INC. | $22.24 | 2019 | |
| Botanix Sb INC | $21.98 | 2025 | Sofdra |
| Sebela Pharmaceuticals INC. | $21.72 | 2021 | |
| Biofrontera INC. | $19.16 | 2019 | |
| Mission Pharmacal Company | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Hisler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.